Bridgeway Capital Management, LLC Chembio Diagnostics, Inc. Transaction History

Bridgeway Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$4.95 - $10.5 $68,805 - $145,950	-13,900 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$7.8 - $11.1 $85,020 - $120,990	-10,900 Reduced 43.95%	13,900 $154,000
Q1 2018 May 15, 2018	SELL	$7.05 - $9.0 $389,865 - $497,700	-55,300 Reduced 69.04%	24,800 $198,000
Q3 2017 Nov 14, 2017	BUY	$5.85 - $6.2 $468,585 - $496,620	80,100	80,100 $497,000

Ticker CEMI
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,224,600
Description
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgeway Capital Management, LLC with notifications on news.